Related Experiment Video
Updated: Aug 3, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis
Martina Uzzo1,2, Umberto Maggiore3, Filippo Sala1,4
1Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Microscopic polyangiitis (MPA) patients diagnosed more recently show less severe kidney disease and a reduced risk of end-stage kidney disease (ESKD). However, the risk of MPA relapse has increased, while the risk of death remains comparable.
Area of Science:
- Nephrology
- Rheumatology
- Internal Medicine
Background:
- Diagnosis and management of microscopic polyangiitis (MPA) have evolved.
- It remains unclear if clinical presentation, histological findings, and patient/renal outcomes have changed over time.
Purpose of the Study:
- To compare clinical and histopathological characteristics at diagnosis.
- To assess changes in the risk of death, end-stage kidney disease (ESKD), and relapse rate in MPA patients over time.
Main Methods:
- Retrospective analysis of 187 MPA patients diagnosed between 1980-2022, divided into two periods: 1980-2001 and 2002-2022.
- Comparison of clinical and histopathological features, mortality, ESKD risk, and relapse rates using statistical models including Kaplan-Meier, Cox-regression, Aalen-Johansen, and Fine-Gray regression.
Main Results:
- Patients diagnosed between 2002-2022 were older, had better kidney function (higher eGFR), and lower prevalence of severe sclerotic lesions compared to 1980-2001.
- The risk of ESKD significantly decreased in the later period (HR 0.30, P < 0.001), with results sustained after adjustments.
- Relapse risk was numerically higher in the 2002-2022 period (HR 1.64, P = 0.075), while patient survival was comparable between groups.
Conclusions:
- MPA kidney involvement has become less severe over recent decades.
- This has led to a reduced risk of ESKD but an increased relapse rate.
- The risk of death associated with MPA has remained comparable across the studied periods.
More Related Videos
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024